Clinical Trial Update: Sorafenib Alone Versus Sorafenib Combined With HAIC for Advanced HCC [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing sorafenib alone to sorafenib plus hepatic arterial infusion chemotherapy (HAIC) in advanced hepatocellular carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• HAIC (hepatic artery infusion chemotherapy)
• Sorafenib (Sorafenib)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Hepatocellular Carcinoma | Phase 3 | Status: COMPLETED